ABOUT RISEN
Risen Group
Corporate Culture
Development History
Management Team
Partners
R&D
PIPELINE
CLINICAL
RP901
RP902
RP903
NEWS
Company news
IP granted
Publications
CONTACT US
CAREERS
Working at Risen
Job opportunities
Employee welfare
繁体
简体
RISEN PHARMA
ABOUT RISEN
Risen Group
Corporate Culture
Development History
Management Team
Partners
R&D
PIPELINE
CLINICAL
RP901
RP902
RP903
NEWS
Company news
IP granted
Publications
CONTACT US
CAREERS
Working at Risen
Job opportunities
Employee welfare
Company news
IP granted
Publications
2024-03-07
Risen's innovative KRAS drug research result has been selected for presentation at the AACR Annual Meeting 2024 in San Diego, California!
Details
Year:
All
2024
2023
2022
2021
2020
2024-03-07
Risen's innovative KRAS drug research result has been selected for presentation at the AACR Annual Meeting 2024 in San Diego, California!
Detail
2023-12-20
Risen found status in the "2023 Hurun Global Cheetah Enterprise List"
Detail
2023-06-13
Congratulations! Risen successfully acquired Biosafety Laboratory level 2 (BSL-2) qualification.
Detail
2023-04-10
Congratulations! Risen laned in “KPMG China Biotech Future Sector 50 Ranking”
Detail
2023-03-13
Congratulations! Risen was entitled as a "special and innovative" small to medium-sized enterprise in Shanghai
Detail
2023-02-03
First in China: ANGPTL3 siRNA drug developed Risen and TopAlliance jointly approved for clinical trial.
Detail
上一页
1
2
下一页
Shanghai Zhangjiang R&D Center.
Suzhou Industrial Park R&D Center.
Shanghai Lingang Industrial Base.
send mail
Copyright 2022 Risen(Shanghai) Pharma Tech Co., Ltd. All Rights Reserved
沪ICP备16020731号-1
Design by:
yushangweb